N@N

PERKINELMER INCORPORATED (NYSE:PKI), Down By 11.48% ($2.99) From $26.040 After BUYINS.NET Report Predicted Stock Would Go Down

^{Published on 2011-08-03 05:29:10 - WOPRAI}
 

August 3, 2011 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net , a provider of unique trading technologies, released a report on Tuesday, June 21st 2011 stating that PERKINELMER INCORPORATED (NYSE:PKI) was expected to go Down due to the Bearish conditions presented in the following report. Click here to view the BUYINS.NET report: http://www.buyins.net/releases/?sym=pki&id=173964

At the time this story was written, PERKINELMER INCORPORATED (NYSE:PKI) is Down By $2.99 (11.48%) since the BUYINS.NET report was released.

The movement of stock prices in the days and weeks leading to and following specific fundamental or technical events may follow a predictable pattern. Many companies stock price histories show random or unpredictable movements around certain events. But some seem to repeat the same pattern quarter after quarter, year after year. We use powerful computers to uncover those events and correlations to generate predictions with high probabilities of generating very specific returns within very specific time periods.

The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php

PERKINELMER INCORPORATED (NYSE:PKI) - PerkinElmer, Inc. provides technology, services, and solutions to the diagnostics, research, environmental, safety and security, industrial and laboratory services markets. PerkinElmer has the portfolios of functional cellular science research technologies, as well as GPCR and kinase products used in researching approximately 75% of drug pathways. The company operates through two segments, Human Health and Environmental Health. The Human Health segment provides early detection for genetic disorders from pre-conception to early childhood, as well as medical imaging for the diagnostics market; and a suite of solutions, including reagents, liquid handling, and detection technologies that enable researchers to improve the drug discovery process. This segment focuses on the cellular research; clinical genetics and diagnostics; cord blood banking and research; drug discovery; life science research and discovery; medical imaging technologies; and pharmaceutical development and manufacturing areas. The Environmental Health segment includes products and services that address the analytical sciences and laboratory service and support markets. This segment focuses on the consumer product safety; environmental analysis; food, flavors, and agricultural analysis; forensic analysis; lubricants and oils; illumination and detection analysis; petrochemical analysis; polymers; renewable energy; and semiconductor and electronics areas. The companys customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. It sells products and accessories primarily through its direct sales force, as well as through distributors. PerkinElmer was founded in 1931 and is headquartered in Waltham, Massachusetts.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market-maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor market-maker surveillance system tracking Level II market-makers in all stocks to determine Price Friction and compliance with new "Fair Market-Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 30 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies specifically for this report, but may have been compensated up to $1,200 per month in the past for unrelated data or report services. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact: BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net http://www.buyins.net